Home > Signaling Pathways

Classified by application

All Products

Signaling Pathways

Research Areas


Nature products




Raw Materials

Signaling Pathways

Chemical Structure Cat. No. Product Name CAS No.
PXL51107 Chemical Structure
BCP28928 PXL51107 1627929-55-8
PLX51107 is a novel structurally distinct BET inhibitor that inhibits all four BET family proteins BRD2, BRD3, BRD4, and BRDT with low nanomolar potency.
Nidufexor Chemical Structure
BCP28929 Nidufexor 1773489-72-7
Nidufexor is a farnesoid X receptor (FXR) agonist.
Nampt-IN-1 Chemical Structure
BCP25239 Nampt-IN-1 1698878-14-6
Nampt-IN-1, also known as LSN3154567, is a potent and elective NAMPT inhibitor.
Pradefovir Chemical Structure
BCP28900 Pradefovir 625095-60-5
Pradefovir, also known as Remofovir, ICN-2001-3; MB-06866; MB-6866; ICN-20013, is a reverse transcriptase inhibitor potentially for treatment of chronic HBV infection.
MB 07133 Chemical Structure
BCP28904 MB 07133 685111-92-6
MB07133 is a novel cytarabine (araC) prodrug that uses the HepDirect technology to target production of the active form of araC, araC triphosphate (araCTP), to the liver.
 GTS-21 Chemical Structure
BCP28897 GTS-21 148372-04-7
2,4-Dimethoxybenzylidene Anabaseine selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner.
 LYN-1604 Chemical Structure
BCP28888 LYN-1604 2088939-99-3
LYN-1604 is a novel activator of ULK1, inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.
 LYN-1604 hydrochloride Chemical Structure
BCP28889 LYN-1604 hydrochloride LYN-1604HLC
LYN-1604 hydrochloride is a potent ULK1 agonist with an EC50 of 18.94 nM.
 LYC-55716 Chemical Structure
BCP28882 LYC-55716 2055536-64-4
LYC-55716 is novel oral RAR-related orphan receptor γ (RORγ) agonist.
 GSK872 Chemical Structure
BCP28887 GSK872 1346546-69-7
GSK872 (GSK2399872A) is a a receptor interacting protein kinase-3 (RIP3) inhibitor.
123下一页末页共 3774 条记录 1 / 378 页